Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Nautilus Biotechnology Inc shares valued at $78,544 were purchased by Patel Sujal M on Sep 05 ’25. At $0.67 per share, Patel Sujal M acquired 116,500 shares. The insider’s holdings grew to 10,258,221 shares worth approximately $7.28 million following the completion of this transaction.
Also, Patel Sujal M purchased 83,500 shares, netting a total of over 57,031 in proceeds. Following the buying of shares at $0.68 each, the insider now holds 10,341,721 shares.
Before that, Murphy Matthew B. had added 20,000 shares to its account. In a trade valued at $12,858, the General Counsel bought Nautilus Biotechnology Inc shares for $0.64 each. Upon closing the transaction, the insider’s holdings increased to 20,000 shares, worth approximately $52639.399999999994.
As published in a research note from Goldman on December 05, 2024, Nautilus Biotechnology Inc [NAUT] has been rated down from a Neutral to a Sell and the price target has been revised to $1.75. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in late June. Earlier on January 06, 2022, Morgan Stanley initiated its rating. Their recommendation was “an Equal-weight” for NAUT stock.
Analyzing NAUT Stock Performance
On last trading session, Nautilus Biotechnology Inc [NASDAQ: NAUT] rose 5.52% to $0.71. The stock’s lowest price that day was $0.7, but it reached a high of $0.75 in the same session. During the last five days, there has been a surge of approximately 10.64%. Over the course of the year, Nautilus Biotechnology Inc shares have dropped approximately -72.27%. Shares of the company reached a 52-week high of $2.1100 on 01/21/25 and a 52-week low of $0.6200 on 09/04/25.
Support And Resistance Levels for Nautilus Biotechnology Inc (NAUT)
According to the 24-hour chart, there is a support level at 0.6880, which, if violated, would cause prices to drop to 0.6690. In the upper region, resistance lies at 0.7380. The next price resistance is at 0.7690. RSI (Relative Strength Index) is 51.44 on the 14-day chart, showing neutral technical sentiment.
Is Nautilus Biotechnology Inc subject to short interest?
Stocks of Nautilus Biotechnology Inc saw a sharp steep in short interest on 2025-08-15 dropping by 16531.0 shares to 0.22 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 0.24 million shares. A decline of -7.36% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 1.16 of the overall float, the days-to-cover ratio (short ratio) decline to 1.16.
Which companies own the most shares of Nautilus Biotechnology Inc (NAUT)?
In terms of Nautilus Biotechnology Inc share price expectations, FactSet research, analysts set an average price target of 2.5 in the next 12 months, up nearly 273.13% from the previous closing price of $0.67. Analysts anticipate Nautilus Biotechnology Inc stock to reach 2.5 by 2025, with the lowest price target being 2.5. In spite of this, 3 analysts ranked Nautilus Biotechnology Inc stock as Buy at the end of 2025.
